Search Medical Condition
Please enter condition
Please choose location from dropdown

Psychosis Clinical Trials

A listing of Psychosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (1094) clinical trials

A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ADJUNCTIVE PIMAVANSERIN FOR THE TREATMENT OF SCHIZOPHRENIA

Phase

A phase III study to evaluate weight gain of ALKS3831 compared to olanzapine in adults with schizophre

Phase

INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED, FIXED-DOSE STUDY OF Lu AF35700 IN PATIENTS WITH TREATMENT-RESISTANT SCHIZOPHRENIA

Phase

A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia

Phase

A phase III study to evaluate weight gain of ALKS3831 compared to olanzapine in adults with schizophrenia

Phase

Interventional, randomized, double-blind, active-controlled, fixed-dose study of Lu AF35700 in patients with treatment-resistant schizophrenia

Phase

A Randomized, Open-label, Multiple-dose, Parallel Design, Comparative Bioequivalence Study of Paliperidone Palmitate Extended-Release Injectable Suspension (156 mg/1.0 mL) Versus Invega Sustenna® (paliperidone palmitate) Extended-Release Injectable Suspension (156mg/1.0 mL) in Schizophrenia Patients Already Stabilized on Paliperidone Palmitate

Phase N/A

INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED, FIXED-DOSE STUDY OF Lu AF35700 IN PATIENTS WITH TREATMENT-RESISTANT SCHIZOPHRENIA

Phase

The purpose of this study is to test the safety of GW8556553 (the study drug) and how well it works at different doses. We are doing this study in patients with depression (Major Depressive Disorder) to find out: 1. What are the effects of the drug, good or bad? 2. ...

Phase

A clinical research study is underway, evaluating an investigational study drug for adults with Parkinson's Disease who are experiencing a decline in memory and thinking.

Phase